Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development of a novel, rapid assay for detection of heparin-binding defect antithrombin deficiencies: the heparin-antithrombin binding (HAB) ratio.

Thrombosis research - 1 Jan 2015

Moore Gary W, de Jager Naomi, Cutler Jacqueline A

Abstract excerpt

INTRODUCTION: Qualitative and quantitative antithrombin deficiency predisposes to thrombosis, although patients with heparin-binding dysfunction have a lower incidence than other sub-types. Assays discriminating between qualitative sub-types are not widely available. PATIENTS/METHODS: Extended heparin incubation in antithrombin activity assays can overestimate levels in patients with HBDs. Plasmas from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antithrombin III Deficiency
Share to Antithrombins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cattle

Share to Factor Xa

Share to Hemostasis

Share to Heparin

Share to Reproducibility of Results

Share to Thrombin

Source

Identifiers

PMID: 25466846
DOI: 10.1016/j.thromres.2014.10.023

Genes

HBD

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development of a novel, rapid assay for detection of heparin-binding defect antithrombin deficiencies: the heparin-antithrombin binding (HAB) ratio.PMID 25466846Read ↗

Antithrombin heparin binding site deficiency: A challenging diagnosis of a not so benign thrombophilia.Semantic proximity Read ↗

Revisiting antithrombin in health and disease, congenital deficiencies and genetic variants, and laboratory studies on α and β forms.Semantic proximity Read ↗

The phenotypic and genetic assessment of antithrombin deficiency.Semantic proximity Read ↗

Diagnostic Performance of Commercial Antithrombin Activity Assays: Do We Get What We Expect?Semantic proximity Read ↗

Investigation of the Differences in Antithrombin to Heparin Binding among Antithrombin Budapest 3, Basel, and Padua Mutations by Biochemical and In Silico Methods.Semantic proximity Read ↗

Progressive chromogenic anti-factor Xa assay and its use in the classification of antithrombin deficiencies.Semantic proximity Read ↗

Heparin binding affinity of normal and genetically modified antithrombin III measured using a monoclonal antibody to the heparin binding site of antithrombin III.Semantic proximity Read ↗

Two new antithrombin variants support a role for K114 and R13 in heparin binding.Semantic proximity Read ↗

Amelioration of the severity of heparin-binding antithrombin mutations by posttranslational mosaicism.Semantic proximity Read ↗

Measurement of von Willebrand factor-FVIII binding activity in patients with suspected von Willebrand disease type 2N: application of an ELISA-based assay in a reference laboratory.Semantic proximity Read ↗

Patients with paroxysmal nocturnal hemoglobinuria demonstrate a prothrombotic clotting phenotype which is improved by complement inhibition with eculizumab.Semantic proximity Read ↗

Inhibition of dysthrombins Quick I and II by heparin cofactor II and antithrombin.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.